GC Corp. (KRX:005250)
South Korea · Delayed Price · Currency is KRW 16,290
+630 (4.02%)
At close: May 20, 2026
GC Corp. Company Description
Green Cross Holdings Corporation operates as a biotechnology company.
The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu.
It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia.
The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies.
Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.
Contact Details
Address: 107, Ihyeon-ro 30beon-gil Yongin-Si South Korea | |
| Phone | 82 3 1260 9300 |
Stock Details
| Ticker Symbol | 005250 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7005250006 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yong-Jun Huh | Chief Executive Officer and Director |